Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...

The RNA analysis market is poised for significant growth due to rising demand in precision medicine, advancements in NGS technologies, and expanding use of RNA biomarkers in diagnostics and drug ...

TECH is set to report Q2 results on Feb. 4, with EPS seen at 43 cents and revenues at $292M as tariffs, NIH funding and segment shifts shape outlook.

Background Asthma is an umbrella diagnosis encompassing distinct pathophysiological mechanisms. While a global problem, our ...